Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma Article

Swanson, HI, Choi, EY, Helton, WB et al. (2014). Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma . Oral surgery, oral medicine, oral pathology and oral radiology, 117(2), 214-220. 10.1016/j.oooo.2013.10.012

cited authors

  • Swanson, HI; Choi, EY; Helton, WB; Gairola, CG; Valentino, J

abstract

  • Objective Apigenin and kaempferol are plant flavonoids with reported chemopreventive activities. This study aimed to determine the effect of apigenin and kaempferol on cell viability in cultured cells derived from the pharynx (FaDu cell line), an oral cavity carcinoma (PCI-13 cell line), and a metastatic lymph node (PCI-15B cell line) and in explanted FaDu cells. Study Design The in vitro viability of FaDu, PCI-13, and PCI-15B cells treated with apigenin and kaempferol was determined. Tumor growth of FaDu explants was evaluated in athymic mice that were gavaged with either apigenin or kaempferol. Results Although apigenin and kaempferol treatment decreased viability of cells in vitro, cell-type-dependent differences in responsiveness were observed. In vivo apigenin treatment significantly increased the tumor size of FaDu explants. Results obtained using kaempferol were similar. Conclusions The in vitro decrease in FaDu cell viability by apigenin and kaempferol was not observed in in vivo tumor explants using the conditions described in this study. © 2014 Elsevier Inc. All rights reserved.

authors

publication date

  • February 1, 2014

published in

Digital Object Identifier (DOI)

start page

  • 214

end page

  • 220

volume

  • 117

issue

  • 2